✦ LIBER ✦
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
✍ Scribed by Laurent-Puig, P.; Cayre, A.; Manceau, G.; Buc, E.; Bachet, J.-B.; Lecomte, T.; Rougier, P.; Lievre, A.; Landi, B.; Boige, V.; Ducreux, M.; Ychou, M.; Bibeau, F.; Bouche, O.; Reid, J.; Stone, S.; Penault-Llorca, F.
- Book ID
- 118261922
- Publisher
- American Society of Clinical Oncology
- Year
- 2009
- Tongue
- English
- Weight
- 175 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.